Assidi, M.; Hakamy, S.; Jafri, M.A.; Al-Thubaity, F.; Al-Maghrabi, J.; Alrefaei, A.F.; Kadasah, S.F.; Nedjadi, T.; Messaoudi, S.A.; Pushparaj, P.N.;
et al. Cytoplasmic Claudin 6 Expression and Copy Number Variations as a Prognosticator of Survival and Relapse in Ovarian Cancer Patients. J. Mol. Pathol. 2026, 7, 26.
https://doi.org/10.3390/jmp7030026
AMA Style
Assidi M, Hakamy S, Jafri MA, Al-Thubaity F, Al-Maghrabi J, Alrefaei AF, Kadasah SF, Nedjadi T, Messaoudi SA, Pushparaj PN,
et al. Cytoplasmic Claudin 6 Expression and Copy Number Variations as a Prognosticator of Survival and Relapse in Ovarian Cancer Patients. Journal of Molecular Pathology. 2026; 7(3):26.
https://doi.org/10.3390/jmp7030026
Chicago/Turabian Style
Assidi, Mourad, Sahar Hakamy, Mohammad A. Jafri, Fatima Al-Thubaity, Jaudah Al-Maghrabi, Abdulmajeed F. Alrefaei, Sultan F. Kadasah, Taoufik Nedjadi, Safia A. Messaoudi, Peter N. Pushparaj,
and et al. 2026. "Cytoplasmic Claudin 6 Expression and Copy Number Variations as a Prognosticator of Survival and Relapse in Ovarian Cancer Patients" Journal of Molecular Pathology 7, no. 3: 26.
https://doi.org/10.3390/jmp7030026
APA Style
Assidi, M., Hakamy, S., Jafri, M. A., Al-Thubaity, F., Al-Maghrabi, J., Alrefaei, A. F., Kadasah, S. F., Nedjadi, T., Messaoudi, S. A., Pushparaj, P. N., Chaudhary, A., Buhmeida, A., & Abu-Elmagd, M.
(2026). Cytoplasmic Claudin 6 Expression and Copy Number Variations as a Prognosticator of Survival and Relapse in Ovarian Cancer Patients. Journal of Molecular Pathology, 7(3), 26.
https://doi.org/10.3390/jmp7030026
